Company
Mestag Therapeutics LTD
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Mestag Therapeutics LTD. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
- Martinus Adrianus Van OschDirector · since 2025
- Charles DunnDirector · since 2023
- Dr Diana BernsteinDirector · since 2022
- Professor Ton LogtenbergDirector · since 2022
- Issi RozenDirector · since 2021
- Dr Fiona Caroline MaclaughlinDirector · since 2021
- Dr Andrew Neil Charles WeirDirector · since 2020
- Dr Susan HillDirector · since 2020
- Dame Catherine Elizabeth BinghamDirector · since 2020
Previous officers 7
- Dr Antoine Boulanger Piette 2024-2025 View profile
- Juliette Audet 2021-2024 View profile
- Shaan-Chirag Chandrahas Gandhi 2021-2022 View profile
- Kevin Lee 2020-2021 View profile
- Professor Houman Ashrafian 2020-2023 View profile
- James Allister John Costine 2020-2020 View profile
- Jonathan Alan Dines 2020-2020 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 17/02/2020
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- SV7 (IMF) GP LLP ceased 2021-07-16
75-100% shares, 75-100% voting, appoints directors · notified 2020-02-17
Group
- Mestag Therapeutics LTD
is controlled by SV7 (IMF) GP LLP
Evidence
ceased 75-100% shares, 75-100% voting, appoints directors · notified 2020-02-17, ceased 2021-07-16 · source: Companies House PSC register - SV7 (IMF) GP LLP
is controlled by SV Health Investors UK Limited
Evidence
active 25-50% voting (LLP), 25-50% surplus assets (LLP), right to appoint and remove members (LLP) · notified 2019-01-17 · source: Companies House PSC register - SV Health Investors UK Limited
is controlled by Catherine Elizabeth Bingham
Evidence
active 50-75% shares, 50-75% shares (firm), 50-75% voting · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Catherine Elizabeth Bingham.
28 other companies in this group
- DDF 2 FP LP
- Harness Therapeutics Limited
- DDF 2 FP GP LLP
- DDF 2 GP LLP
- DDF Chemco Limited
- Dementia Discovery General Partner LLP
- SV BCO I FP GP LLP
- SV8 Biotech FP LP
- Loqus23 Therapeutics Limited
- Cybele Therapeutics LTD
- DDF Parallel LLP
- SV8 BIO FP GP LLP
- SV Health Investors UK Limited
- SV8 BIO GP LLP
- SV Health Managers LLP
- SV Health Investors LLP
- SV DDF Number 1 Limited
- SV BCO I GP LLP
- SV7 (IMF) FP LP
- Alchemab Therapeutics LTD
- 10279592
- SV DDF Number 2 Limited
- Cellinta LTD
- Dementia Discovery GP LP
- SV7 (IMF) FP GP LLP
- Endlyz UK LTD
- SV BCO I FP LP
- SV7 (IMF) GP LLP
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Grants received
1 grant · £634,954 total360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.
Top funders
- Department for Science, Innovation and Technology · £634,954
Most recent
- Department for Science, Innovation and Technology
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
9 directors on the board
- Dr Diana Bernstein Director · appointed 2022
- Professor Ton Logtenberg Director · appointed 2022
- Dr Andrew Neil Charles Weir Director · appointed 2020
- Dr Susan Hill Director · appointed 2020
- Dame Catherine Elizabeth Bingham Director · appointed 2020
- Charles Dunn Director · appointed 2023
- Dr Fiona Caroline Maclaughlin Director · appointed 2021
- Martinus Adrianus Van Osch Director · appointed 2025
- Issi Rozen Director · appointed 2021
Directors past 6 years
- Dr Andrew Neil Charles Weir Director · appointed 2020
- Dr Susan Hill Director · appointed 2020
- Dame Catherine Elizabeth Bingham Director · appointed 2020
First-time vs portfolio directors
First-time (6)
- Dr Diana Bernstein Director · appointed 2022
- Professor Ton Logtenberg Director · appointed 2022
- Dr Susan Hill Director · appointed 2020
- Charles Dunn Director · appointed 2023
- Martinus Adrianus Van Osch Director · appointed 2025
- Issi Rozen Director · appointed 2021
Portfolio (3)
- Dr Andrew Neil Charles Weir Director · appointed 2020
- Dame Catherine Elizabeth Bingham Director · appointed 2020
- Dr Fiona Caroline Maclaughlin Director · appointed 2021
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Narrow spread of sectors across the board
Where to look Suggested search: directors from a wider range of sectors.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 12466144
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data